Anders Johansson Selected Research

leukotoxin

5/2022	The Highly Leukotoxic JP2 Genotype of Aggregatibacter actinomycetemcomitans Is Present in the Population of the West African Island, Sal in Cape Verde: A Pilot Study.
2/2022	Discrepancies in Antimicrobial Susceptibility between the JP2 and the Non-JP2 Genotype of Aggregatibacter actinomycetemcomitans.
7/2020	Characterization of Aggregatibacter actinomycetemcomitans Serotype b Strains with Five Different, Including Two Novel, Leukotoxin Promoter Structures.
1/2017	Systemic Aggregatibacter actinomycetemcomitans Leukotoxin-Neutralizing Antibodies in Periodontitis.
1/2016	Effects of Aggregatibacter actinomycetemcomitans leukotoxin on neutrophil migration and extracellular trap formation.
1/2015	Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitis.
1/2014	Leukotoxic activity of Aggregatibacter actinomycetemcomitans and periodontal attachment loss.
3/2011	Prevalence of systemic immunoreactivity to Aggregatibacter actinomycetemcomitans leukotoxin in relation to the incidence of myocardial infarction.
6/2005	The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Johansson Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 06/2022 - 03/2008
13	Periodontitis 05/2022 - 06/2005
11	Neoplasms (Cancer) 01/2020 - 01/2004
10	Infections 01/2022 - 03/2006
8	Pain (Aches) 01/2022 - 03/2003
7	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 09/2016
6	Inflammation (Inflammations) 11/2019 - 07/2012
5	Hemorrhage 12/2020 - 01/2005
5	Obesity 10/2016 - 06/2011
4	Aggressive Periodontitis (Periodontosis) 02/2022 - 09/2014
4	Periodontal Diseases (Periodontal Disease) 01/2020 - 01/2005
4	Tularemia 12/2016 - 01/2002
4	Bone Resorption 01/2014 - 02/2006
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2007 - 12/2002
3	Obstructive Sleep Apnea 01/2022 - 12/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2003
3	Insulin Resistance 01/2020 - 01/2015
3	Tooth Erosion 12/2018 - 01/2005
3	Dyskinesias (Dyskinesia) 01/2018 - 03/2008
2	Vomiting 01/2022 - 03/2003
2	Xerostomia 01/2022 - 02/2020
2	Asthma (Bronchial Asthma) 10/2020 - 01/2019
2	Genetic Risk Score 01/2020 - 01/2019
2	Tinnitus 09/2019 - 01/2013
2	Peri-Implantitis 02/2019 - 01/2018
2	Dental Fluorosis 01/2019 - 12/2018
2	Dental Caries (Decay, Dental) 01/2019 - 12/2018
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 03/2005
2	Postoperative Pain 02/2018 - 03/2003
2	Typhoid Fever (Typhoid) 01/2018 - 06/2014
2	Dementia (Dementias) 01/2018 - 06/2015
2	Body Weight (Weight, Body) 01/2016 - 01/2008
2	Lung Neoplasms (Lung Cancer) 08/2015 - 01/2006
2	Malignant Mesothelioma 08/2015 - 01/2006
2	Disease Progression 01/2013 - 04/2007
2	Nausea 11/2009 - 03/2003
2	Chronic Periodontitis 07/2007 - 06/2005
1	Feeding and Eating Disorders (Eating Disorder) 01/2022
1	Bulimia (Binge Eating) 01/2022
1	Bronchitis 10/2020

Drug/Important Bio-Agent (IBA)

9	leukotoxinIBA 05/2022 - 06/2005
8	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 03/2008
8	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2003
6	Carbidopa (Lodosyn)FDA LinkGeneric 06/2022 - 03/2008
6	AntibodiesIBA 01/2020 - 06/2005
5	Immunoglobulin G (IgG)IBA 06/2019 - 06/2015
4	Virulence Factors (Pathogenicity Factors)IBA 11/2019 - 06/2008
4	InterleukinsIBA 11/2019 - 02/2006
4	CytokinesIBA 01/2018 - 02/2006
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2004
3	Amyloid (Amyloid Fibrils)IBA 04/2021 - 09/2016
3	ApolipoproteinsIBA 12/2020 - 01/2019
3	AntigensIBA 01/2020 - 08/2012
3	MetalsIBA 01/2020 - 07/2007
3	Immunoglobulin M (IgM)IBA 01/2018 - 06/2015
3	Messenger RNA (mRNA)IBA 01/2018 - 02/2006
3	EnzymesIBA 01/2018 - 06/2015
2	PlasticsIBA 01/2022 - 01/2019
2	CobaltIBA 10/2020 - 07/2007
2	C-Reactive ProteinIBA 11/2019 - 03/2015
2	QuartzIBA 11/2019 - 01/2019
2	TitaniumIBA 02/2019 - 06/2010
2	LignansIBA 12/2018 - 03/2005
2	ORALIT (ORS)IBA 12/2018 - 02/2012
2	Ropivacaine (Naropin)FDA LinkGeneric 02/2018 - 03/2003
2	ImmunosorbentsIBA 01/2018 - 06/2015
2	Thrombin FDA Link 01/2017 - 08/2012
2	melanin-concentrating hormone receptorIBA 10/2016 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 01/2006
2	globotriaosylceramide (globotriosylceramide)IBA 08/2015 - 10/2010
2	melanin-concentrating hormone (melanin concentrating hormone)IBA 02/2015 - 06/2011
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 09/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2009
2	cytolethal distending toxinIBA 01/2013 - 06/2005
2	Oxygen (Dioxygen)IBA 07/2012 - 05/2011
2	Pharmaceutical PreparationsIBA 10/2010 - 01/2006
2	Bacterial ToxinsIBA 02/2009 - 01/2006
2	Therapeutic UsesIBA 03/2008 - 01/2006
2	OsteoprotegerinIBA 07/2007 - 02/2006
1	SolutionsIBA 06/2022
1	SugarsIBA 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	AcidsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 11/2021
1	Methoxyflurane (Penthrane)FDA Link 11/2021
1	Tuberculin (PPD)IBA 12/2020
1	Apomorphine FDA Link 11/2020

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2006
5	Oral Hygiene (Dental Hygiene) 01/2022 - 07/2012
4	Dental Care 02/2020 - 08/2004
3	Analgesia 02/2018 - 03/2003
3	Aftercare (After-Treatment) 01/2017 - 12/2004
2	Oral Administration 07/2021 - 01/2008
2	Splints (Splint) 09/2019 - 01/2013
2	Critical Care (Surgical Intensive Care) 01/2013 - 01/2004
2	Drug Therapy (Chemotherapy) 10/2010 - 01/2006
1	Intravenous Infusions 06/2022
1	Occlusal Splints 01/2022
1	Arthroplasty 01/2022
1	Precision Medicine 07/2021